184 related articles for article (PubMed ID: 24101379)
1. Cgnz1 allele confers kidney resistance to damage preventing progression of immune complex-mediated acute lupus glomerulonephritis.
Ge Y; Jiang C; Sung SS; Bagavant H; Dai C; Wang H; Kannapell CC; Cathro HP; Gaskin F; Fu SM
J Exp Med; 2013 Oct; 210(11):2387-401. PubMed ID: 24101379
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune experimental orchitis and chronic glomerulonephritis with end stage renal disease are controlled by Cgnz1 for susceptibility to end organ damage.
Zhao Z; Qiao H; Ge Y; Kannapel CC; Sung SJ; Gaskin F; Tung KSK; Fu SM
Clin Immunol; 2021 Mar; 224():108675. PubMed ID: 33482358
[TBL] [Abstract][Full Text] [Related]
3. Genetic approach to study lupus glomerulonephritis.
Ge Y; Brown MG; Wang H; Fu SM
Methods Mol Biol; 2012; 900():271-90. PubMed ID: 22933074
[TBL] [Abstract][Full Text] [Related]
4. Interferon alpha on NZM2328.Lc1R27: enhancing autoimmunity and immune complex-mediated glomerulonephritis without end stage renal failure.
Dai C; Wang H; Sung SS; Sharma R; Kannapell C; Han W; Wang Q; Davidson A; Gaskin F; Fu SM
Clin Immunol; 2014 Sep; 154(1):66-71. PubMed ID: 24981059
[TBL] [Abstract][Full Text] [Related]
5. NZM2328: a new mouse model of systemic lupus erythematosus with unique genetic susceptibility loci.
Waters ST; Fu SM; Gaskin F; Deshmukh US; Sung SS; Kannapell CC; Tung KS; McEwen SB; McDuffie M
Clin Immunol; 2001 Sep; 100(3):372-83. PubMed ID: 11513551
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms governing the progression of nephritis in lupus prone mice and human lupus patients.
Daamen AR; Wang H; Bachali P; Shen N; Kingsmore KM; Robl RD; Grammer AC; Fu SM; Lipsky PE
Front Immunol; 2023; 14():1147526. PubMed ID: 36936908
[TBL] [Abstract][Full Text] [Related]
7. Role for nephritogenic T cells in lupus glomerulonephritis: progression to renal failure is accompanied by T cell activation and expansion in regional lymph nodes.
Bagavant H; Deshmukh US; Wang H; Ly T; Fu SM
J Immunol; 2006 Dec; 177(11):8258-65. PubMed ID: 17114504
[TBL] [Abstract][Full Text] [Related]
8. Lupus-prone strains vary in susceptibility to antibody-mediated end organ disease.
Xie C; Du Y; Kumar K; Li L; Han J; Liu K; Zhou XJ; Mohan C
Genes Immun; 2013 Apr; 14(3):170-8. PubMed ID: 23392277
[TBL] [Abstract][Full Text] [Related]
9. Glomerular capillary and endothelial cell injury is associated with the formation of necrotizing and crescentic lesions in crescentic glomerulonephritis.
Fujita E; Nagahama K; Shimizu A; Aoki M; Higo S; Yasuda F; Mii A; Fukui M; Kaneko T; Tsuruoka S
J Nippon Med Sch; 2015; 82(1):27-35. PubMed ID: 25797872
[TBL] [Abstract][Full Text] [Related]
10. Failure of CD25+ T cells from lupus-prone mice to suppress lupus glomerulonephritis and sialoadenitis.
Bagavant H; Tung KS
J Immunol; 2005 Jul; 175(2):944-50. PubMed ID: 16002693
[TBL] [Abstract][Full Text] [Related]
11. Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis.
Waters ST; McDuffie M; Bagavant H; Deshmukh US; Gaskin F; Jiang C; Tung KS; Fu SM
J Exp Med; 2004 Jan; 199(2):255-64. PubMed ID: 14718514
[TBL] [Abstract][Full Text] [Related]
12. Dependence of Glomerulonephritis Induction on Novel Intraglomerular Alternatively Activated Bone Marrow-Derived Macrophages and Mac-1 and PD-L1 in Lupus-Prone NZM2328 Mice.
Sung SJ; Ge Y; Dai C; Wang H; Fu SM; Sharma R; Hahn YS; Yu J; Le TH; Okusa MD; Bolton WK; Lawler JR
J Immunol; 2017 Apr; 198(7):2589-2601. PubMed ID: 28219886
[TBL] [Abstract][Full Text] [Related]
13. A Central Role for HLA-DR3 in Anti-Smith Antibody Responses and Glomerulonephritis in a Transgenic Mouse Model of Spontaneous Lupus.
Chowdhary VR; Dai C; Tilahun AY; Hanson JA; Smart MK; Grande JP; Rajagopalan G; Fu SM; David CS
J Immunol; 2015 Nov; 195(10):4660-7. PubMed ID: 26475924
[TBL] [Abstract][Full Text] [Related]
14. Lupus glomerulonephritis revisited 2004: autoimmunity and end-organ damage.
Bagavant H; Deshmukh US; Gaskin F; Fu SM
Scand J Immunol; 2004; 60(1-2):52-63. PubMed ID: 15238073
[TBL] [Abstract][Full Text] [Related]
15. The role of aldosterone blockade in murine lupus nephritis.
Monrad SU; Killen PD; Anderson MR; Bradke A; Kaplan MJ
Arthritis Res Ther; 2008; 10(1):R5. PubMed ID: 18197980
[TBL] [Abstract][Full Text] [Related]
16. Enhanced susceptibility to end-organ disease in the lupus-facilitating NZW mouse strain.
Xie C; Zhou XJ; Liu X; Mohan C
Arthritis Rheum; 2003 Apr; 48(4):1080-92. PubMed ID: 12687552
[TBL] [Abstract][Full Text] [Related]
17. Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis.
Schiffer L; Bethunaickan R; Ramanujam M; Huang W; Schiffer M; Tao H; Madaio MP; Bottinger EP; Davidson A
J Immunol; 2008 Feb; 180(3):1938-47. PubMed ID: 18209092
[TBL] [Abstract][Full Text] [Related]
18. Microthrombotic Renal Vascular Lesions Are Associated to Increased Renal Inflammatory Infiltration in Murine Lupus Nephritis.
Gonzalo-Gil E; García-Herrero C; Toldos O; Usategui A; Criado G; Pérez-Yagüe S; Barber DF; Pablos JL; Galindo M
Front Immunol; 2018; 9():1948. PubMed ID: 30210500
[No Abstract] [Full Text] [Related]
19. The SLAM family member CD48 (Slamf2) protects lupus-prone mice from autoimmune nephritis.
Koh AE; Njoroge SW; Feliu M; Cook A; Selig MK; Latchman YE; Sharpe AH; Colvin RB; Paul E
J Autoimmun; 2011 Aug; 37(1):48-57. PubMed ID: 21561736
[TBL] [Abstract][Full Text] [Related]
20. Infusion of anti-DFS70 antibodies prolonged survival of lupus-prone mice.
Aljadeff G; Shemer A; Katz I; Andrade LEC; Gilburd B; Halpert G; Mahler M; Blank M; Amital H; Shoenfeld Y
Lupus; 2021 Feb; 30(2):320-324. PubMed ID: 33175665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
